相关实验视频
Updated: Feb 8, 2026

06:24
Minimal Erythema Dose MED Testing
Published on: May 28, 2013
42.9K
低剂量比没有剂量更好:是时候考虑降低美国最小血小板转化率了吗?
Ludwig Frontier1, Alyssa Ziman2, Barbara J Bryant3
1Macopharma, Medical Affairs, Duluth, GA, USA.
概括
美国面临的血小板供应挑战. 低产量的血小板是有效和安全的,这表明对当前美国法规的审查可能会改善可用性和供体负担.
科学领域:
- 血液学 血液学 血液学
- 输血医学 输血医学
- 监管科学 监管科学
背景情况:
- 美国的血小板供应受到高监管标准,更少的捐赠者和需求增加的压力.
- 目前的美国法规要求每单位的血小板产量至少为3.0×1011,超过国际标准.
- 细菌风险减轻策略增加了低产血小板单位,使它们成为国家库存的重要组成部分.
研究的目的:
- 评估低产血小板的疗效和安全性.
- 分析2022-2024年美国血小板利用趋势.
- 确定是否应该重新考虑美国对血小板产量的监管标准.
主要方法:
- 分析2022年至2024年美国血小板利用数据.
- 对低产血小板的静血疗效的临床证据的审查.
- 美国监管标准与国际实践的比较.
主要成果:
- 尽管存在供应压力,低产血小板单位的比例保持稳定,而血小板单位的分裂减少.
- 低产量的血小板在患有骨髓衰竭的患者中显示出与标准产量的组件相似的静血疗效.
- 输血实践可以影响整体血小板利用率,特别是当低产量的单位普遍存在时.
结论:
- 由于供应限制和安全使用的国际证据,建议修订美国的最小血小板转化产量要求.
- 将美国法规与全球标准相协调,可以提高血小板的可用性,减轻捐赠者的负担,提高供应弹性.
- 需要进一步的研究来确认不同患者群体的结果.
相关概念视频
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
258
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
258
Dose Size and Dosing Frequency: Determination Methods
312
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
312
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
246
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
246
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.5K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.5K
Dose-Response Relationship: Overview
5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
Drug Dosing: Infants and Children
309
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
309

